- Q4 2023 Lisata Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$3.21 (+4.61%)Earnings
- Q3 2023 Lisata Therapeutics Inc Earnings Call TranscriptNov 02, 2023$2.15 (+5.88%)Earnings
- Q2 2023 Lisata Therapeutics Inc Earnings Call TranscriptAug 15, 2023$2.71Earnings
- Lisata Therapeutics Inc Fireside Chat Hosted by H.C. Wainwright & Co LLC (Virtual) TranscriptJun 21, 2023
- Q1 2023 Lisata Therapeutics Inc Earnings Call TranscriptMay 09, 2023$3.18Earnings
- Q4 2022 Lisata Therapeutics Inc Earnings Call TranscriptMar 30, 2023$3.33Earnings
- Lisata Therapeutics Inc at OTC Markets Life Science Investor Forum (Virtual) TranscriptMar 09, 2023
- Q3 2022 Lisata Therapeutics Inc Earnings Call TranscriptNov 10, 2022$4.06Earnings
- Q2 2022 Caladrius Biosciences Inc Earnings Call TranscriptAug 04, 2022$7.46 (+0.24%)Earnings
- Caladrius Biosciences Inc Provides Update on Phase 2b FREEDOM Trial Conference Call and Webcast TranscriptMay 24, 2022
- Q1 2022 Caladrius Biosciences Inc Earnings Call TranscriptMay 05, 2022$7.82Earnings
- Caladrius Biosciences Inc & Cend Therapeutics Definitive Merger Agreement Call TranscriptApr 27, 2022
- Q4 2021 Caladrius Biosciences Inc Earnings Call TranscriptMar 22, 2022$10.97 (-1.16%)Earnings
- Q3 2021 Caladrius Biosciences Inc Earnings Call TranscriptNov 04, 2021$17.55 (+0.80%)Earnings
- Q2 2021 Caladrius Biosciences Inc Earnings Call TranscriptAug 05, 2021$19.79 (+2.68%)Earnings
- Caladrius Biosciences Inc at LD Micro Virtual Zooming Conference TranscriptJul 29, 2021
- Q1 2021 Caladrius Biosciences Inc Earnings Call TranscriptMay 06, 2021$22.65 (-3.08%)Earnings
- Q4 2020 Caladrius Biosciences Inc Earnings Call TranscriptFeb 25, 2021$29.85 (-2.21%)Earnings
- Q3 2020 Caladrius Biosciences Inc Earnings Call TranscriptNov 05, 2020$35.1Earnings
- Q2 2020 Caladrius Biosciences Inc Earnings Call TranscriptAug 13, 2020$34.2Earnings
- Caladrius Biosciences Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- Q1 2020 Caladrius Biosciences Inc Earnings Call TranscriptMay 07, 2020$28.2Earnings
- Q4 2019 Caladrius Biosciences Inc Earnings Call TranscriptMar 05, 2020$44.25Earnings
- Q3 2019 Caladrius Biosciences Inc Earnings Call TranscriptNov 06, 2019$44.25Earnings
- Q2 2019 Caladrius Biosciences Inc Earnings Call TranscriptAug 08, 2019$44.25Earnings
- Q1 2019 Caladrius Biosciences Inc Earnings Call TranscriptMay 09, 2019$54Earnings
Caladrius Biosciences Inc Provides Update on Phase 2b FREEDOM Trial Conference Call and Webcast Transcript
Welcome to the Caladrius Biosciences FREEDOM trial status update conference call. (Operator Instructions) As a reminder, this call is being recorded today, Tuesday, May 24, 2022.
I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Caladrius. Please go ahead, sir.
Thank you, operator, and good morning everyone. Welcome to Caladrius' conference call for an update on the status of the FREEDOM trial of XOWNA in coronary microvascular dysfunction. Joining me today from our management team are Dr. David Mazzo, President and Chief Executive Officer and Dr. Kristen Buck, Executive Vice President of Research and Development and Chief Medical Officer.
Last evening, we issued a press release on the status update which is available under the Investors and News section of the company website, along with the webcast replay of this call. If you've not received this news release or would like to be added to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)